| Registry | NCT03292393 |
|---|---|
| Status | Withdrawn - Not enough sample list at participating healthcare facility. |
| Phase | Not applicable |
| Study type | Interventional; randomized, factorial, masking: triple, health services research |
| Sponsor | Florida International University (Other) |
| Conditions | Hypertension, Medication Adherence |
| Interventions | Financial reward, Social norms, Home Blood Pressure Monitoring, Medication adherence assessment (Behavioral, device) |
| Dates | start 2018-09-01 (estimated), primary completion 2019-09-01 (estimated), completion 2020-03-01 (estimated), first posted 2017-09-25, last updated 2018-11-07 |
Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Hypertension All trials for Medication Adherence All trials of Financial reward All trials of Social norms
The study objective is to build group social norms to improve individual adhere to antihypertensive medications. Financial incentives are provided to individuals contingent upon group behavioral changes. Groups of patients will be formed, and incentivized to interact on a daily basis through social media and participate in a monthly-facilitated meeting at a local clinic. By forming groups, making individual outcomes transparent, and setting financial incentives contingent to group targets, individual decisions are framed within emerging social norms.
We propose a pilot study that will inform, provide inputs and reduce the risk of a larger implementation. The project consists of three phases: The pre-intervention phase, the intervention phase, and the post-intervention phase. The pre-intervention phase includes the recruitment and selection of participants, and a one-month collection of baseline blood pressure and medication adherence levels of participants before they are assigned to a treatment arm. All participants will receive compensation for participation.
In the intervention phase participants will be randomly assigned to one of the three treatment arms and they will receive the financial incentive that corresponds to their treatment arm. Data will be collected for four months and all participants will continue receiving a compensation for participation.
During the post-intervention phase, contingency payments will be cut off, and only compensation for participation will remain. Data will be collected for three months in the post-intervention phase.
The primary outcome of the study is medication adherence which will be measured using two different methods. The first method is through the use of eCaps (electronic caps). The second method is through a monthly randomized phone call during which the participant will be asked to perform a pill count of their medication.
The secondary outcome of the study is blood pressure which will be measured using two different instruments . The first instrument will be the ambulatory blood pressure monitor (ABPM). The second instrument will be a home blood pressure monitor (HBPM) which researchers will provide to the participant to use for the duration of the study.
All participants of the study will receive an unconditional payment each time they provide a blood pressure reading from the ABPM. Financial incentives (contingent to change in behavior -conditional to change in adherence). In addition to the unconditional payment, participants in the ICM and GCM treatment arms will receive a financial incentive that is conditional to medication adherence.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Group Contingency Management | Active comparator | Behavioral: Financial reward; Behavioral: Social norms; Device: Home Blood Pressure Monitoring; Device: Medication adherence assessment | During the intervention phase, the Group Contingency Management (GCM) arm will continue to take their hypertensive medication for the four-month period and will receive a randomized phone call once a month to obtain a pill count and a home blood pressure monitoring reading using the HBPM. Participants in the GCM arm will receive a payment after each phone call, dependent on their medication adherence assessment. The GCM arm will also receive an additional payment based on their group's medication adherence.The intervention administered is the Financial Reward and Social Norms. |
| Individual Contingency Management | Active comparator | Behavioral: Financial reward; Device: Home Blood Pressure Monitoring; Device: Medication adherence assessment | During the intervention phase, those in the Individual Contingency Management (ICM) arm will also continue to take their hypertensive medication for the four-month period but will receive a payment after each phone call, dependent on their medication adherence assessment.The intervention administered is the Financial Reward. |
| Control Arm | Placebo comparator | Device: Home Blood Pressure Monitoring; Device: Medication adherence assessment | During the intervention phase, those in the control arm will be asked to continue to take their hypertensive medication for the four-month period and will receive a randomized phone call once a month to obtain a pill count and a blood pressure reading using the HBPM. Those in the control arm will only be paid for their participation in the study regardless of medication adherence assessment. |
Sex: All, ages: 35 Years to 65 Years, accepts healthy volunteers
Inclusion Criteria: * Person has been diagnosed with essential hypertension for at least a year (no new or recently diagnosed hypertensive patients) * Person is currently taking no more than 2 medications * Person has taken the same anti-hypertensive medication for at least a year (no recent changes in medication) * Person reports not being adherent to anti-hypertensive medication * Speaks English or Spanish, currently insured * Has access to the Internet * Willing to participate in social media, able to go to West Kendall Baptist Hospital * Available for the next 8 months Exclusion Criteria: * Persons with Secondary hypertension * Persons with coronary heart disease, cerebrovascular disorders or atrial fibrillation, * Persons with rubber allergy, or bedridden, wheelchair bound. * Persons who have had a stroke or myocardial infarction within the previous 6 months, are pregnant, or have any serious chronic disease will also be excluded from the study.